PERSPECTA

News from every angle

← Back to headlines

Novo Nordisk Foundation to Launch Obesity Drug Incubators in Europe

The Novo Nordisk Foundation, owner of Novo Nordisk, announced plans to establish incubators across Europe to support obesity researchers in bringing new treatments to market. This initiative aims to help accelerate the development and commercialization of obesity drugs.

19 Jun, 05:00 — 19 Jun, 05:00
PostShare

Sources

Showing 1 of 2 sources
bloombergHigh3d ago

Novo Nordisk Owner to Open Obesity Drug Incubators Across Europe - Bloomberg.com

Novo Nordisk Owner to Open Obesity Drug Incubators Across Europe  Bloomberg.com

Read full article →

Coverage Timeline

First report: bloomberg · 19 Jun, 05:00Full coverage: 2 · 2mWindow: 2m
Left-leaningCenterRight-leaning
bloomberg19 Jun, 05:00First to report

Novo Nordisk Owner to Open Obesity Drug Incubators Across Europe - Bloomberg.com

berlingske19 Jun, 05:01Latest update

Novo-fond vil hjælpe fedmeforskere med at få midler på markedet

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

just now

Rotterdam-based Nearfield Instruments Raises €331 Million in Deeptech Funding

17m ago

Website Aggregates Betting Offers

21m ago

Microsoft's AI Strategy Aims for Cheap Models and Infrastructure Ownership

30m ago